The proposed legislation, titled the "End Organ and Genomic Harvesting Act," aims to prohibit certain practices related to human organ transplants and genetic analysis technologies. Specifically, it prohibits health benefit plans from covering human organ transplants or post-transplant care if the transplant occurs in countries known for forced organ harvesting, such as the People's Republic of China. Additionally, the act restricts the use of genetic sequencers and analysis technologies produced by foreign adversaries, mandating that medical and research facilities in Arkansas refrain from using such technologies starting October 1, 2025. Facilities must also report their usage of these technologies and ensure that genetic sequencing data is stored securely outside of foreign adversary countries.

The bill includes definitions for key terms such as "forced organ harvesting," "health benefit plan," and "healthcare insurer," and outlines the responsibilities of the Insurance Commissioner in designating countries involved in forced organ harvesting. It establishes penalties for violations, including fines for entities that fail to comply with the regulations. Furthermore, the act includes a severability clause to ensure that if any part of the legislation is deemed invalid, the remaining provisions will still be enforceable.